Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines: Pertaining to ST-segment-elevation myocardial infarction

Texas Heart Institute Journal

Volumn 35, Issue 2, 2008, Pages 152-161

  Peacock, W Frank ^a   Bhatt, Deepak L ^a   Diercks, Deborah ^b   Amsterdam, Ezra ^b   Chandra, Abhinav ^c   Ohman, E Magnus ^d   Brown, David F M ^e   Januzzi, James ^e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angioplasty, transluminal, percutaneous coronary standards utilization; Cardiovascular diseases epidemiology mortality; Chronology as topic; Delivery of health care standards; Fibrinolysis; Guideline adherence; Hospitals standards

Indexed keywords

FIBRINOLYTIC AGENT;

CARDIOLOGIST; EMERGENCY PHYSICIAN; FIBRINOLYSIS; HEALTH SURVEY; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; INTERNET; KNOWLEDGE; MEDICAL SOCIETY; PERCEPTION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; REVIEW; ST SEGMENT ELEVATION; SUBURBAN AREA; UNITED STATES; URBAN AREA;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATTITUDE OF HEALTH PERSONNEL; CARDIOLOGY; CLINICAL COMPETENCE; EMERGENCY MEDICINE; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; THROMBOLYTIC THERAPY; UNITED STATES;

EID: 47249083468     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Cavendish JJ, Fugit RV, Safani M. Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromes. Curr Med Res Opin 2004;20(11):1839-43.
2. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44(3):E1-E211.
3. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published errata appear in Circulation 2006;113(14):e696 and Circulation 2006;114(23):e630]. Circulation 2006;113(6):e85-151.
4. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348(9030):771-5.
5. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004;109(10):1223-5.
6. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group [published erratum appears in Lancet 1994;343(8899):742]. Lancet 1994;343(8893):311-22.
7. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 2003;92(7):824-6.
8. Hahn SA, Chandler C. Diagnosis and management of ST elevation myocardial infarction: a review of the recent literature and practice guidelines. Mt Sinai J Med 2006;73(1):469-81.
9. Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, et al.; Vienna STEMI Registry Group. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 2006;113(20):2398- 405.
10. Magid DJ, Wang Y, Herrin J, McNamara RL, Bradley EH, Curtis JP, et al. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA 2005;294(7):803-12.
11. McNamara RL, Herrin J, Bradley EH, Portnay EL, Curtis JP, Wang Y, et al; NRMI Investigators. Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol 2006;47(1):45-51.
12. Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH, Krumholz HM; NRMI Investigators. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005;111(6):761-7.
13. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24(1):28-66.
14. McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, et al.; NRMI Investigators. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006;47(11):2180-6.
15. Brodie BR, Hansen C, Stuckey TD, Richter S, Versteeg DS, Gupta N, et al. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol 2006;47(2):289-95.
16. Luepker RV, Raczynski JM, Osganian S, Goldberg RJ, Finnegan JR Jr, Hedges JR, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA 2000;284(1):60-7.
17. Smalling RW. Role of fibrinolytic therapy in the current era of ST-segment elevation myocardial infarction management. Am Heart J 2006;151(6 Suppl):S17-23.
18. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, et al.; CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004;292(17):2096-104.
19. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361(9351):13-20.
20. Alter DA, Ko DT, Newman A, Tu JV. Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction. Eur Heart J 2006;27(13):1539-49.
21. Rajagopal V, Bhatt DL. Gaps in myocardial infarction care: how might we best EFFECT change? Eur Heart J 2006;27(13):1513-4.
22. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006;114(19):2019-25.